Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 1/20 | 0.42 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.39 |
| ▸ | SLC9A1 | P19634 | 3/20 | 0.37 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.34 |
| ▸ | HTT | P42858 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | GALR3 | O60755 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3302887 | 0.98 | TBXAS1 (0.46) | TBXAS1TLR8CYP19A1SLC9A1SMPD1 | |
| SCHEMBL245126 | 0.98 | TBXAS1 (0.46) | TBXAS1TLR8CYP19A1SLC9A1SMPD1 | |
| SCHEMBL245885 | 0.98 | TBXAS1 (0.46) | TBXAS1TLR8CYP19A1SLC9A1SMPD1 | |
| SCHEMBL243704 | 0.98 | TBXAS1 (0.46) | TBXAS1TLR8CYP19A1SLC9A1SMPD1 | |
| SCHEMBL21925549 | 0.98 | TBXAS1 (0.46) | TBXAS1TLR8CYP19A1SLC9A1SMPD1 | |
| SCHEMBL20204363 | 0.98 | TBXAS1 (0.46) | TBXAS1TLR8CYP19A1SLC9A1SMPD1 | |
| SCHEMBL11204798 | 0.98 | TBXAS1 (0.46) | TBXAS1TLR8CYP19A1SLC9A1SMPD1 | |
| Sulfuric Acid SCHEMBL16340543 | 0.89 | ALDH1A1 (0.38) | TBXAS1TLR8CYP19A1SLC9A1SMPD1 | |
| SCHEMBL9634208 | 0.88 | MGLL (0.45) | TBXAS1 | |
| SCHEMBL18723226 | 0.88 | TBXAS1 (0.35) | TBXAS1TLR8CYP19A1SLC9A1SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11939336-B2 | Aryl triazole cages | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2024-03-26 | — | — | US | claimed |
| WO-2023239909-A1 | TRIAZOLE SYNTHESIS, COMPOSITIONS, SYSTEMS AND METHODS | DOBER CHEMICAL CORP. (US) | 2023-12-14 | — | — | WO | claimed |
| CN-114671816-B | Preparation method of axial chiral aryl triazole compound | 浙江大学 | 2023-11-17 | — | — | CN | claimed |
| US-11649256-B2 | Catalysts for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-05-16 | — | — | US | claimed |
| US-20230128348-A1 | TREATMENT OF HYPERINFLAMMATORY SYNDROME | Remicine IP B.V. (NL) | 2023-04-27 | — | — | US | claimed |
| EP-4125843-A1 | TREATMENT OF HYPERINFLAMMATORY SYNDROME | Nomoreitis B.V. (BE) | 2023-02-08 | — | — | EP | claimed |
| CN-115605194-A | Treatment of excessive inflammatory syndrome | 诺莫雷蒂斯私人有限公司（BE） | 2023-01-13 | — | — | CN | claimed |
| CN-114671816-A | Preparation method of axial chiral aryl triazole compound | 浙江大学 | 2022-06-28 | — | — | CN | claimed |
| CN-114478504-A | CD-ROM molecular motor artificial ion transmission system with antibacterial and anti-tumor activities and application thereof | 华东理工大学 | 2022-05-13 | — | — | CN | claimed |
| US-20210363150-A1 | ARYL TRIAZOLE CAGES | UNITED STATES DEPARTMENT OF ENERGY | 2021-11-25 | — | — | US | claimed |
| EP-0686691-A1 | Aqueous emulsions with brighteners | THE PROCTER & GAMBLE COMPANY (US) | 1995-12-13 | — | — | EP | claimed |
| WO-1994024234-A1 | AMIDE/ESTER HETEROCYCLIC DERIVATIVES OF HYDROCARBYLSUCCINIC ANHYDRIDRES AS RUST/CORROSION INHIBITORS ADDITIVES FOR LUBRICANTS | MOBIL OIL CORPORATION (US) | 1994-10-27 | — | — | WO | claimed |
| US-5348674-A | Heat and wear resistant composition with hydroxy amines and aryltriazoles | MOBIL OIL CORPORATION (US) | 1994-09-20 | — | — | US | claimed |
| US-5120456-A | Wear, oxidation and corrosion resistance | MOBIL OIL CORP. (US) | 1992-06-09 | — | — | US | claimed |
| EP-0422369-A2 | Substituted carbamoyltriazoles | BAYER AG (DE) | 1991-04-17 | — | — | EP | claimed |
| EP-0185401-B1 | HETEROCYCLIC HERBICIDES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1990-06-06 | — | — | EP | claimed |
| EP-0029972-B1 | PREPARATION FOR BRIGHTENING SYNTHETIC FIBRES, PROCESS FOR ITS PREPARATION AND PROCESS FOR OPTICAL BRIGHTENING | CASSELLA Aktiengesellschaft (DE) | 1984-09-19 | — | — | EP | claimed |
| US-4415629-A | Insulated conductor | ELECTRIC POWER RESEARCH INSTITUTE, INC. (US) | 1983-11-15 | — | — | US | claimed |
| US-4304569-A | Formulation for brightening synthetic fibers and its preparation and use | CASSELLA AG. (DE) | 1981-12-08 | — | — | US | claimed |
| US-4094634-A | Anionic and nonionic emulsified optical brightener suspension with a hydrotropic agent | CIBA GEIGY AG (CH) | 1978-06-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11939336-B2 | Aryl triazole cages | CAT, SOD1, SOD3 | TBXAS1 3362/4885TLR8 3521/4885CYP19A1 2856/4885 |
| US-11649256-B2 | Catalysts for olefin polymerization | CDK13, CYP2A13, ORC3 | TBXAS1 1629/4885TLR8 3361/4885CYP19A1 106/4885 |
| US-20210363150-A1 | ARYL TRIAZOLE CAGES | CAT, SOD1, SOD3 | TBXAS1 3362/4885TLR8 3521/4885CYP19A1 2856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.